.

Board of Directors

Christopher B. Begley

Christopher B. Begley

Retired Executive Chairman and Chief Executive Officer, Hospira, Inc.

View More

Christopher B. Begley

Retired Executive Chairman and Chief Executive Officer, Hospira, Inc.

Director Since 2012

Executive Chairman of the Board of Hospira, Inc. from May 2007 until his retirement in January 2012. Mr. Begley also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division. He earned a bachelor’s degree from Western Illinois University and an MBA from Northern Illinois University.

Other Public Board Memberships

  • DeVry Education Group Inc.(Non-Executive Chair)
  • Hanger, Inc.
  • Past director and Non-Executive Chairman of The Hillshire Brands Company (until August 2014)
  • Past director of Sara Lee Corporation (until June 2012)
  • Past director and Executive Chairman of Hospira, Inc. (until January 2012)

Other Relevant Experience

  • Past director of the Advanced Medical Technology Association (“AdvaMed”), the medical device industry’s trade association
  • Past director of the National Center for Healthcare Leadership

Member of the Compensation and Management Development Committee

Member of the Quality, Regulatory and Technology Committee

Betsy J. Bernard

Betsy J. Bernard

Retired President, AT&T Corp.

View More

Betsy J. Bernard

Retired President, AT&T Corp.

Director Since 2009

President of AT&T Corp. from October 2002 until her retirement in December 2003. From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer. Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell. Ms. Bernard received a B.A. degree from St. Lawrence University, an MBA from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program.

Other Public Board Memberships

  • Principal Financial Group, Inc.
  • Past director of SITO Mobile Ltd. (until June 2017)
  • Past director of Telular Corporation (until June 2013)

Member of the Audit Committee

Chair of the Corporate Governance Committee

Gail K. Boudreaux

Gail K. Boudreaux

Chief Executive Officer and Founder, GKB Global Health, LLC

View More

Gail K. Boudreaux

Chief Executive Officer and Founder, GKB Global Health, LLC

Director Since 2012

Chief Executive Officer and Founder, GKB Global Health, LLC from 2015 to present. Ms. Boudreaux served as Chief Executive Officer of UnitedHealthcare from January 2011 to November 2014 and Executive Vice President of UnitedHealth Group from May 2008 to February 2015. From 2005 to 2008, Ms. Boudreaux served as Executive Vice President, External Operations for Health Care Services Corporation (“HCSC”), and prior to that served as President of Blue Cross and Blue Shield of Illinois, a division of HCSC. Before joining HCSC, Ms. Boudreaux held various positions at Aetna, including Senior Vice President, Aetna Group Insurance. Ms. Boudreaux earned a bachelor's degree in psychology from Dartmouth College and an MBA from Columbia Business School.

Other Public Board Memberships

  • Xcel Energy Inc.
  • Novavax, Inc.

Member of the Audit Committee

Member of the Corporate Governance Committee

Michael J. "Mick" Farrell

Michael J. "Mick" Farrell

Chief Executive Officer, ResMed Inc.

View More

Michael J. "Mick" Farrell

Chief Executive Officer, ResMed Inc.

Director Since 2014

Chief Executive Officer of ResMed Inc. since March 2013. Prior to that appointment, Mr. Farrell served as President – Americas for ResMed from 2011 to 2013. He was previously Senior Vice President of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development. Before joining ResMed in September 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company and BHP Billiton. Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology and an MBA from the MIT Sloan School of Management.

Other Public Board Memberships

  • ResMed Inc.

Other Relevant Experience

  • Director of AdvaMed

Member of the Compensation and Management Development Committee

Member of the Corporate Governance Committee

Daniel P. Florin

Daniel P. Florin

Interim Chief Executive Officer, Senior Vice President and Chief Financial Officer

View More

Daniel P. Florin

Interim Chief Executive Officer, Senior Vice President and Chief Financial Officer

Director Since July 2017

Dan Florin was appointed Interim Chief Executive Officer and a member of the Board of Directors on July 11, 2017. In addition, he serves as Senior Vice President and Chief Financial Officer, a position he has held since June 2015. 

Mr. Florin served as Senior Vice President and Chief Financial Officer of Biomet from June 2007 to June 2015.  Prior to joining Biomet, Mr. Florin served as Vice President and Corporate Controller of Boston Scientific Corporation from 2001 until 2007.  Before being appointed Corporate Controller in 2001, Mr. Florin served in financial leadership positions within Boston Scientific Corporation and its various business units.  Prior to joining Boston Scientific Corporation, Mr. Florin worked for C.R. Bard from October 1990 through June 1995, and was employed by Deloitte from September 1986 to October 1990.  Mr. Florin holds a Bachelor’s degree in Business Administration with a concentration in Accounting from the University of Notre Dame and an Executive MBA from Boston University.

Larry C. Glasscock

Larry C. Glasscock

Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Chairman, President and Chief Executive Officer, Anthem, Inc.

View More

Larry C. Glasscock

Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Chairman, President and Chief Executive Officer, Anthem, Inc.

Director Since 2001; Non-Executive Chairman Since May 2013

Chairman of WellPoint, Inc. (now Anthem, Inc.) from 2005 until 2010. Mr. Glasscock also served as President and Chief Executive Officer of WellPoint, Inc. from 2004 to 2007. Mr. Glasscock served as Chairman, President and Chief Executive Officer of Anthem, Inc. from 2003 to 2004 and served as President and Chief Executive Officer of Anthem, Inc. from 2001 to 2003. Mr. Glasscock earned a B.B.A. from Cleveland State University. He also completed the Commercial Bank Management Program at Columbia University.

Other Public Board Memberships

  • Simon Property Group, Inc. (Lead Independent Director)
  • Sysco Corporation
  • Past director of Sprint Nextel Corporation (until July 2013)
  • Past director and Chairman of Anthem, Inc. (until March 2010)

Member of the Audit Committee

Member of the Corporate Governance Committee

Robert A. Hagemann

Robert A. Hagemann

Retired Senior Vice President and Chief Financial Officer, Quest Diagnostics Incorporated

View More

Robert A. Hagemann

Retired Senior Vice President and Chief Financial Officer, Quest Diagnostics Incorporated

Director Since 2008

Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated until his retirement in July 2013. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998. Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

Other Public Board Memberships

  • Graphic Packaging Holding Company
  • Ryder System, Inc.

Chair of the Audit Committee

Member of the Quality, Regulatory and Technology Committee

Arthur J. Higgins

Arthur J. Higgins

President, Chief Executive Officer and Director, Depomed, Inc.

View More

Arthur J. Higgins

President, Chief Executive Officer and Director, Depomed, Inc.

Director Since 2007

President, Chief Executive Officer and a member of the board of directors of Depomed, Inc. since March 2017. Consultant, Blackstone Healthcare Partners of the Blackstone Group since June 2010. Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Other Public Board Memberships

  • Depomed, Inc.
  • Ecolab Inc.
  • Past director of Endo International plc (until March 2017)
  • Past director of Resverlogix Corp. (until February 2014)

Other Relevant Experience

  • Past director of the Pharmaceutical Research and Manufacturers of America
  • Past member of the Council of the International Federation of Pharmaceutical Manufacturers and Associations
  • Past president of the European Federation of Pharmaceutical Industries and Associations

Chair of the Compensation and Management Development Committee

Member of the Quality, Regulatory and Technology Committee

Michael W. Michelson

Michael W. Michelson

Member, KKR Management LLC, the general partner of KKR & Co. L.P.

View More

Michael W. Michelson

Member, KKR Management LLC, the general partner of KKR & Co. L.P.

Director Since 2015

Member, KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P., since October 2009. Before that, Mr. Michelson was a member of the limited liability company that served as the general partner of Kohlberg Kravis Roberts & Co. L.P. since 1996. He joined KKR in 1981. Mr. Michelson has played a significant role in the development of KKR’s portfolio companies. He began his professional career with the law firm of Latham & Watkins in Los Angeles, where he was involved in a broad corporate practice while specializing in management buyouts. He earned an A.B. from Harvard College and a J.D. from Harvard Law School.

Other Public Board Memberships

  • Past director of HCA Holdings, Inc. (until May 2016)
  • Past director of Jazz Pharmaceuticals plc (until January 2012)

Other Relevant Experience

  • Served as a director of Biomet prior to the merger of Zimmer and Biomet

Member of the Compensation and Management Development Committee

Member of the Quality, Regulatory and Technology Committee

Cecil B. Pickett Ph.D.

Cecil B. Pickett Ph.D.

Retired President, Research and Development, Biogen Idec Inc.

View More

Cecil B. Pickett Ph.D.

Retired President, Research and Development, Biogen Idec Inc.

Director Since 2008

President, Research and Development and a member of the board of directors of Biogen Idec Inc. from September 2006 until his retirement in October 2009. Prior to joining Biogen Idec, Dr. Pickett held several senior R&D positions, including Corporate Senior Vice President of Schering-Plough Corp. and President of Schering-Plough Research Institute. Prior to joining Schering-Plough, he held several senior R&D positions at Merck & Co. Dr. Pickett received a B.S. in biology from California State University at Hayward and a Ph.D. in cell biology from University of California at Los Angeles.

Other Public Board Memberships

  • Past director of Biogen Idec (until October 2009)

Other Relevant Experience

  • Member of the Institute of Medicine of The National Academy of Sciences

Member of the Compensation and Management Development Committee

Chair of the Quality, Regulatory and Technology Committee

Jeffrey K. Rhodes

Jeffrey K. Rhodes

Partner, TPG Capital, L.P

View More

Jeffrey K. Rhodes

Partner, TPG Capital, L.P

Director Since 2015

Partner, TPG Capital, L.P. Mr. Rhodes is a leader of the firm’s investment activities in the healthcare services, pharmaceutical and medical device sectors. Prior to joining TPG in 2005, Mr. Rhodes was with McKinsey & Company and Article27 LTD, a start-up software company. He was a founding board member of the Healthcare Private Equity Association, a non-profit trade association that represents the U.S. healthcare private equity industry. Mr. Rhodes earned a B.A. in Economics from Williams College, where he graduated summa cum laude, and an MBA from Harvard Business School, where he was a Baker Scholar.

Other Public Board Memberships

  • Surgical Care Affiliates, Inc.

Other Relevant Experience

  • Served as a director of Biomet prior to the merger of Zimmer and Biomet

Member of the Audit Committee

Member of the Corporate Governance Committee